
    
      Subjects will be randomly assigned to one of three oral mirabegron doses and then randomly
      assigned to one of three oral mirabegron doses and then randomly assigned to one of six
      treatment sequences.

      For all subjects the first treatment will be a reference IV dose. Treatments 2, 3, and 4 will
      be a random order of slow, fast and target release oral doses of mirabegron. Treatment 5 will
      be a target release dose of mirabegron from a different batch.

      There will be at least 10 day washout between dose administrations.
    
  